欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0421/001
药品名称SMOFlipid
活性成分
    • dl-alfa-tocopherol 0.0 mg
    • medium chain triglycerides 60.0 g
    • purified fish oil 30.0 g
    • refined olive oil 50.0 g
    • soybean oil 60.0 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Hungary (HU)
    • Cyprus (CY)
      SMOFLIPID EMULSION FOR INFUSION
    • Czechia (CZ)
    • Slovakia (SK)
      SMOFlipid
    • Slovenia (SI)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      SMOFlipid 200 mg/ml Emulsion zur Infusion
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      SMOFlipid
    • Latvia (LV)
      SMOFlipid 20 % emulsion for infusion
    • Lithuania (LT)
      SMOFlipid 20% infuzinė emulsija
    • Estonia (EE)
许可日期2004/07/06
最近更新日期2024/07/05
药物ATC编码
    • B05BA02 fat emulsions
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase